About ScalmiBio
ScalmiBio is a company based in San Carlos (United States) founded in 2016 by Marija Vrljic was acquired by ALX Oncology in October 2021.. ScalmiBio operates in a competitive market with competitors including Osmol Therapeutics, Secretome Therapeutics, Cell Source, Egetis and Metys Pharmaceuticals, among others.
- Headquarter San Carlos, United States
- Founders Marija Vrljic
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$299.96 K (USD), Grant
Mar 11, 2019
-
Investors
ALX Oncology
& 1 more
-
Employee Count
Employee Count
-
Acquired by
ALX Oncology
(Oct 07, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of ScalmiBio
- Total Funding Total Funding
- Total Rounds 1
- Last Round Grant — $299,957
-
First Round
First Round
(11 Mar 2019)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2019 | Amount | Grant - ScalmiBio | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ScalmiBio
ScalmiBio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include ALX Oncology and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location | |
|
ALX Oncology is focused on advancing cancer treatment therapies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ScalmiBio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ScalmiBio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Scalmibio Comparisons
Competitors of ScalmiBio
ScalmiBio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Osmol Therapeutics, Secretome Therapeutics, Cell Source, Egetis and Metys Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Treatments for chemotherapy-induced peripheral neuropathy are developed.
|
|
| domain | founded_year | HQ Location |
Cell-based therapies for multiple diseases are developed.
|
|
| domain | founded_year | HQ Location |
Cell therapy treatments for transplantation, cancer treatment and reversal of vital organ disease
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare and other diseases are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for chemotherapy-induced peripheral neuropathy and CNS disorders are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about ScalmiBio
When was ScalmiBio founded?
ScalmiBio was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is ScalmiBio located?
ScalmiBio is headquartered in San Carlos, United States. It is registered at San Carlos, California, United States.
What does ScalmiBio do?
ScalmiBio was founded in 2016 and is based in San Carlos, United States. Operations focus on the biotechnology sector, particularly oncology therapeutics. The SHIELD platform technology is utilized to convert therapeutic antibodies into prodrugs activated specifically within tumors. This approach allows for higher dosing of cancer treatments and supports multi-target combination therapies, aiming to reduce systemic side effects.
Who are the top competitors of ScalmiBio?
ScalmiBio's top competitors include Secretome Therapeutics, Osmol Therapeutics and Cell Source.
Who are ScalmiBio's investors?
ScalmiBio has 2 investors. Key investors include ALX Oncology, and HHS.